Dermatologic Manifestations of Scabies Follow-up
- Author: Kelly M Cordoro, MD; Chief Editor: Dirk M Elston, MD more...
Deterrence/Prevention
All household members and close personal contacts older than 2 months and not pregnant should be treated for scabies, even if they have no symptoms or signs of infestation. Detailed directions regarding treatment and environmental control measures should be provided verbally and in writing.
Patients must be evaluated within 2-4 weeks after treatment to ensure compliance and adequate response to therapy. Patients may experience pruritus up to 2 weeks after successful treatment. If itching persists beyond this time, the patient must be reevaluated to ensure correct diagnosis, adequate treatment, and simultaneous treatment of contacts and environment. A second treatment course may be indicated.
Rarely, individuals with a history of atopy may require a tapered dose of prednisone for the treatment of severe pruritus. Intranodular injection of dilute corticosteroids may be necessary in cases of nodular scabies.
Because of the heavy mite burden, cases of crusted scabies may require repeated applications of topical scabicides or simultaneous treatment with a topical agent such as permethrin and oral ivermectin.
Complications
- Treatment failures are uncommon if guidelines are followed.
- Residual pruritus may require antihistamines or a short course of topical or oral corticosteroids.
- Secondary infection requires the use of antibiotics based on culture and sensitivity data. One report describes methicillin-resistant Staphylococcus aureus bacteremia in a patient with crusted scabies.[14]
- Scabietic nodules may require intranodular corticosteroid injection for complete resolution.
- Flaring or reactivation of preexisting eczema or atopic dermatitis requires the use of standard eczema treatments.
Prognosis
Prognosis is excellent with proper diagnosis and treatment in otherwise healthy individuals. Immunocompromised or institutionalized individuals are at an increased risk for crusted scabies, which is associated with a less favorable outcome.
Patient Education
For excellent patient education resources, visit eMedicine's Infections Center, eMedicine's patient education article Scabies, and the American Academy of Dermatology.
Haubrich WS. Medical Meanings: A Glossary of Word Origins. Philadelphia, Pa: American College of Physicians; 1997:200.
Makigami K, Ohtaki N, Ishii N, Yasumura S. Risk factors of scabies in psychiatric and long-term care hospitals: a nationwide mail-in survey in Japan. J Dermatol. Sep 2009;36(9):491-8. [Medline].
Mehta V, Balachandran C, Monga P, Rao R, Rao L. Images in clinical practice. Norwegian scabies presenting as erythroderma. Indian J Dermatol Venereol Leprol. Nov-Dec 2009;75(6):609-10. [Medline].
Hay RJ. Scabies and pyodermas--diagnosis and treatment. Dermatol Ther. Nov-Dec 2009;22(6):466-74. [Medline].
Svecova D, Chmurova N, Pallova A, Babal P. Norwegian scabies in immunosuppressed patient misdiagnosed as an adverse drug reaction. Epidemiol Mikrobiol Imunol. Aug 2009;58(3):121-3. [Medline].
Phan A, Dalle S, Balme B, Thomas L. Scabies with clinical features and positive darier sign mimicking mastocytosis. Pediatr Dermatol. May-Jun 2009;26(3):363-4. [Medline].
Bezold G, Lange M, Schiener R, et al. Hidden scabies: diagnosis by polymerase chain reaction. Br J Dermatol. Mar 2001;144(3):614-8. [Medline].
Johnston G, Sladden M. Scabies: diagnosis and treatment. BMJ. Sep 17 2005;331(7517):619-22. [Medline].
Karthikeyan K. Treatment of scabies: newer perspectives. Postgrad Med J. Jan 2005;81(951):7-11. [Medline].
[Guideline] British Association for Sexual Health and HIV (BASHH). United Kingdom national guideline on the management of scabies infestation. National Guideline Clearinghouse. Feb 15 2008.
Aubin F, Humbert P. Ivermectin for crusted (Norwegian) scabies. N Engl J Med. Mar 2 1995;332(9):612. [Medline].
Huffam SE, Currie BJ. Ivermectin for Sarcoptes scabiei hyperinfestation. Int J Infect Dis. Jan-Mar 1998;2(3):152-4. [Medline].
Elgart GW, Meinking TL. Ivermectin. Dermatol Clin. Apr 2003;21(2):277-82. [Medline].
Lin S, Farber J, Lado L. A case report of crusted scabies with methicillin-resistant Staphylococcus aureus bacteremia. J Am Geriatr Soc. Sep 2009;57(9):1713-4. [Medline].
Brodell RT, Helms SE. Bedside testing: the diagnostic cornerstone of dermatology. Compr Ther. Mar 1997;23(3):211-7. [Medline].
Burgess I. Sarcoptes scabiei and scabies. Adv Parasitol. 1994;33:235-92. [Medline].
Burkhart CG, Burkhart CN, Burkhart KM. An epidemiologic and therapeutic reassessment of scabies. Cutis. Apr 2000;65(4):233-40. [Medline].
Fitzpatrick TB, Austen KF, Wolff K, et al, eds. Dertmatology in General Medicine. 4th ed. New York, NY: McGraw-Hill; 1993:1812-3.
Elgart ML. Scabies. Dermatol Clin. Apr 1990;8(2):253-63. [Medline].
Fitzpatrick TB, Johnson RA, Wolff K. Inset Bites and Infestations. In: Fitzpatrick TJ, Johnson RA, Wolff K, Polano MK, Suurmond R, eds. Color Atlas and Synopsis of Clinical Dermatology. 3rd ed. New York, NY: McGraw-Hill; 1997:836-61.
Guldbakke KK, Khachemoune A. Crusted scabies: a clinical review. J Drugs Dermatol. Mar 2006;5(3):221-7. [Medline].
McCarthy JS, Kemp DJ, Walton SF, Currie BJ. Scabies: more than just an irritation. Postgrad Med J. Jul 2004;80(945):382-7. [Medline].
Molinaro MJ, Schwartz RA, Janniger CK. Scabies. Cutis. Dec 1995;56(6):317-21. [Medline].
Orkin M, Maibach HI. Scabies treatment: current considerations. Curr Probl Dermatol. 1996;24:151-6. [Medline].
Paller AS. Scabies in infants and small children. Semin Dermatol. Mar 1993;12(1):3-8. [Medline].
Schleicher SM, Stewart P. Scabies: the mite that roars. Emerg Med. 1997;6:54-8.

